Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas.

@article{Volm1998PrognosticVO,
  title={Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas.},
  author={M. Volm and Werner Rittgen and Peter Drings},
  journal={British Journal of Cancer},
  year={1998},
  volume={77},
  pages={663 - 669}
}
Patients with previously untreated squamous cell lung carcinomas were evaluated to see if combining the expression of molecular and cellular factors with the most important clinical prognostic factors could improve the diagnostic ability to predict prognosis. For this reason, immunohistochemistry was used to examine the squamous cell lung carcinomas from 121 patients for their expression of ERBB-1, vascular endothelial growth factor (VEGF), cyclin A, FOS, JUN and MYC. Median survival was… CONTINUE READING
64 Citations
18 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 64 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 18 references

Staging lung cancer

  • DT Carr, CF Mountain
  • Lung Cancer . Clinical Diagnosis and Treatment ,
  • 1977
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…